Skip to main content
Clinical Trials/IRCT20200127046282N33
IRCT20200127046282N33
Not yet recruiting
Phase 1

Investigating the effectiveness of the combination therapy of CO2 fractional laser and conditioned medium derived from foreskin fibroblast cells in the treatment of burn scars compared to CO2 fractional laser alone : Phase 1 clinical trial

Tehran University of Medical Sciences0 sites18 target enrollmentTBD

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
burn scar.
Sponsor
Tehran University of Medical Sciences
Enrollment
18
Status
Not yet recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Patients with skin type 1\-4
  • Patients with atrophic burn scars in more than one organ from 5 years ago to 3 months ago

Exclusion Criteria

  • Age under 18 years
  • Patients who have received laser treatment in the last three months
  • Patients with active colloidal scar or active skin lesion at the injection site
  • Patients with coagulation and platelet disorders
  • Patients with a history of underlying disease such as diabetes and autoimmune connective tissue disease that affect wound healing
  • Patients with active viral infections
  • Patients with a history of anticoagulants
  • History of malignancy or receiving chemotherapy
  • Pregnancy and lactation

Outcomes

Primary Outcomes

Not specified

Similar Trials